Oridonin: Uses, Mechanism & Research Applications

Oridonin is a bioactive ent-kaurane diterpenoid natural product isolated primarily from Isodon rubescens, widely investigated in research settings for its apoptosis-inducing, anti-inflammatory, and antitumor properties.

Chemical Class

ent-Kaurane diterpenoid

Primary Natural Source

Isodon rubescens (Rabdosia rubescens)

Molecular Formula

C20H28O6

Molecular Weight

364.43 g/mol

Key Research Activities

Apoptosis induction, NF-κB inhibition, anti-inflammatory, antitumor

Recommended Storage

Store at -20 °C, protect from light and moisture

What Is Oridonin and Where Does It Come From?

Oridonin is a naturally occurring ent-kaurane diterpenoid first isolated from Isodon rubescens (also known as Rabdosia rubescens), a medicinal herb used in traditional Chinese medicine. The compound belongs to the structurally diverse kauranoid diterpenoid family and features a characteristic tetracyclic skeleton with multiple hydroxyl and epoxide functional groups that underpin its biological reactivity.

In research contexts, Oridonin is supplied as a purified solid and serves as a reference compound or biochemical probe for studying pathways relevant to cell death, inflammation, and cancer biology. Its well-defined structure and tractable synthesis have also made it a scaffold for medicinal chemistry efforts aimed at improving potency and selectivity.

Mechanism of Action: How Does Oridonin Work?

Oridonin exerts its biological effects through multiple, partially overlapping mechanisms that have been characterized in cell-based and biochemical assays:

• Apoptosis induction: Oridonin activates both intrinsic (mitochondrial) and extrinsic apoptotic pathways, leading to cytochrome c release, caspase activation, and ultimately programmed cell death in various tumor cell lines.
• NF-κB pathway inhibition: The compound interferes with nuclear factor-kappa B (NF-κB) signaling, a master regulator of inflammation and cell survival, thereby reducing expression of pro-survival and pro-inflammatory genes.
• Cell cycle arrest: Oridonin has been reported to arrest cells at G2/M phase, impairing mitotic progression in cancer cells.
• Reactive oxygen species (ROS) modulation: Elevation of intracellular ROS levels has been proposed as a contributor to Oridonin-induced cytotoxicity, though the precise hierarchy of these events remains under investigation.

Researchers should note that specific mechanistic contributions may vary substantially depending on the cell type and experimental model used.

Solubility, Formulation and Storage Guidelines

Proper handling of Oridonin is essential to ensure experimental reproducibility. The following guidelines reflect generally accepted laboratory practice for this compound class:

• Solubility: Oridonin has limited aqueous solubility. It is soluble in dimethyl sulfoxide (DMSO) and ethanol, making these the preferred vehicles for preparing stock solutions. When diluting into aqueous buffers or cell culture media, vortex thoroughly and prepare fresh working solutions to minimize precipitation.
• Stock solution preparation: Prepare concentrated stock solutions (typically 10–50 mM) in DMSO and store as aliquots to avoid repeated freeze-thaw cycles. Verify the final DMSO concentration in assays does not exceed levels that affect cell viability (commonly ≤0.1% v/v).
• Storage: Store the solid compound at -20 °C in a tightly sealed container, protected from light and moisture. Under these conditions, the compound is expected to be stable; however, researchers should verify purity periodically, especially after prolonged storage.
• Handling: As with any bioactive research compound, standard laboratory PPE should be worn. Consult the Safety Data Sheet (SDS) for specific hazard information.

Research Applications of Oridonin

Oridonin is used across several active areas of biomedical research:

• Oncology research: Oridonin is extensively studied as a cytotoxic and pro-apoptotic agent across multiple cancer cell lines, including leukemia, breast, colorectal, lung, and hepatocellular carcinoma models. It is used both as a single agent and in combination studies to assess synergy with standard chemotherapeutics.
• Inflammation and immunology: Due to its NF-κB inhibitory activity, Oridonin is employed in models of inflammatory disease to probe cytokine regulation, macrophage activation, and innate immune signaling.
• Autophagy research: Emerging evidence suggests Oridonin can modulate autophagic flux, making it a tool compound for dissecting the interplay between autophagy and apoptosis.
• Medicinal chemistry: Oridonin serves as a privileged scaffold for the synthesis of semi-synthetic analogues with improved pharmacological profiles. Structure-activity relationship (SAR) studies frequently utilize Oridonin as the parent compound.
• Traditional medicine validation: Researchers use purified Oridonin to attribute and validate the bioactivities historically ascribed to Isodon rubescens-based herbal preparations.

Quality, Purity and Regulatory Considerations

When selecting Oridonin for research use, purity and characterization data are critical parameters:

• Purity: For mechanistic and biological assays, a purity of ≥98% (typically assessed by HPLC) is recommended to minimize confounding effects from impurities. Always request a Certificate of Analysis (CoA) and confirm the purity specification meets your experimental requirements.
• Characterization: Standard characterization data should include HPLC purity, NMR spectral data, mass spectrometry confirmation of the correct molecular ion, and melting point where applicable.
• Research use only: Oridonin supplied by Aladdin Scientific (SKU: O111381) is intended strictly for laboratory research purposes. It is not approved for use in diagnostic procedures, human therapeutic applications, or veterinary use without appropriate regulatory authorization.
• Lot-to-lot consistency: For longitudinal studies, researchers are advised to reserve sufficient quantity from a single lot, or verify biological activity when switching lots, to maintain experimental consistency.

Frequently asked questions

What is the recommended solvent for dissolving Oridonin?

Oridonin is poorly soluble in water and is best dissolved in DMSO or ethanol to prepare concentrated stock solutions. When introducing the stock into aqueous media or cell culture, dilute gradually with thorough mixing, and keep the final DMSO concentration at or below 0.1% (v/v) to avoid solvent-related cytotoxic artifacts.

What cancer cell lines is Oridonin most commonly used with in research?

Oridonin has been investigated across a broad range of tumor cell lines in the published literature, including leukemia (e.g., HL-60), breast cancer (e.g., MCF-7), colorectal cancer, hepatocellular carcinoma, and lung cancer lines. Researchers should consult the primary literature to identify the most appropriate cell model for their specific biological question, as potency and mechanism can vary by cell type.

How should Oridonin be stored to maintain stability?

The solid form of Oridonin should be stored at -20 °C in a sealed container, protected from light and moisture. Prepared DMSO stock solutions should be aliquoted and stored at -20 °C to avoid repeated freeze-thaw cycles, which can degrade the compound over time. Always verify purity by HPLC if the compound has been stored for an extended period.

Is Oridonin selective for a single molecular target?

No. Oridonin is generally considered a pleiotropic natural product that engages multiple molecular targets and pathways, including NF-κB, caspase cascades, cell cycle regulators, and ROS-generating systems. This polypharmacology is characteristic of many natural diterpenoids. Researchers designing mechanistic studies should include appropriate pathway-specific controls and inhibitors to deconvolute individual contributions.

Can Oridonin be used in in vivo studies?

Oridonin has been used in animal models in the research literature; however, formulation for in vivo administration requires careful consideration of vehicle, dose, and route of administration to achieve adequate bioavailability. Researchers planning in vivo studies should consult the relevant primary literature for formulation details and adhere to all applicable institutional animal ethics requirements. Aladdin Scientific supplies Oridonin (O111381) for research use only.

References

1. Ikezoe T, et al. Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells. Int J Oncol. 2003.
2. Liu J, et al. Oridonin, a natural diterpenoid, exerts anti-inflammatory effects via NF-κB inhibition. General reference — specific journal and volume require verification.
3. Pubchem Compound Summary for CID 159516: Oridonin. National Library of Medicine.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.